new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers
August 2009
You'll see new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers.
This is a surprise. We usually think of Singulair as benign.
But now some patients are reporting insomnia, agitation, anxiety, depression, and similar problems.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote